Genetically engineered stem cells for therapeutic gene delivery
- PMID: 17969558
- DOI: 10.2174/156652307781369119
Genetically engineered stem cells for therapeutic gene delivery
Abstract
Stem cell and gene therapy approaches have held out much hope for the development of new tools to treat disease. Therapeutic approaches based on these methods have only rarely found their way into the clinic. The linking of stem cell therapy with selective gene therapy enhances therapeutic options for the regeneration or replacement of diseased or missing cells. This review focuses on the rationale and preliminary results of combining stem cell and gene therapy. Special emphasis is placed on various molecular techniques currently used to genetically engineer stem cells. Viral and nonviral genes delivering technologies are detailed as are techniques for the modulation of gene expression in the context of stem cell recruitment and differentiation. Finally potential clinical applications for this new therapeutic strategy are discussed.
Similar articles
-
Recent developments in delivery of nucleic acid-based antiviral agents.Curr Pharm Des. 2006;12(16):1995-2006. doi: 10.2174/138161206777442146. Curr Pharm Des. 2006. PMID: 16787243 Review.
-
Non-viral gene transfection technologies for genetic engineering of stem cells.Eur J Pharm Biopharm. 2008 Jan;68(1):90-104. doi: 10.1016/j.ejpb.2007.04.021. Epub 2007 Jul 21. Eur J Pharm Biopharm. 2008. PMID: 17870447 Review.
-
Nonviral gene therapy.Curr Gene Ther. 2001 Jul;1(2):201-26. doi: 10.2174/1566523013348814. Curr Gene Ther. 2001. PMID: 12108955 Review.
-
Nonviral gene therapy: the promise of genes as pharmaceutical products.Hum Gene Ther. 1995 Sep;6(9):1129-44. doi: 10.1089/hum.1995.6.9-1129. Hum Gene Ther. 1995. PMID: 8527471 Review.
-
Nonviral gene delivery: what we know and what is next.AAPS J. 2007 Mar 23;9(1):E92-104. doi: 10.1208/aapsj0901009. AAPS J. 2007. PMID: 17408239 Free PMC article. Review.
Cited by
-
An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.Mol Ther. 2011 Apr;19(4):667-75. doi: 10.1038/mt.2010.287. Epub 2011 Jan 11. Mol Ther. 2011. PMID: 21224831 Free PMC article.
-
Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.Mol Ther. 2011 Sep;19(9):1704-13. doi: 10.1038/mt.2011.93. Epub 2011 May 17. Mol Ther. 2011. PMID: 21587211 Free PMC article.
-
Advancing the Battle against Cystic Fibrosis: Stem Cell and Gene Therapy Insights.Curr Med Sci. 2024 Dec;44(6):1155-1174. doi: 10.1007/s11596-024-2936-5. Epub 2024 Dec 16. Curr Med Sci. 2024. PMID: 39676146 Review.
-
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.Mol Ther Oncolytics. 2023 Aug 15;30:238-253. doi: 10.1016/j.omto.2023.08.004. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37701849 Free PMC article.
-
Mesenchymal stem cells in regenerative medicine: of hopes and challenges.Medscape J Med. 2009;11(1):28. Epub 2009 Jan 28. Medscape J Med. 2009. PMID: 19295949 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical